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Background: The majority of available studies have shown that children with sickle cell disease (SCD) have a
higher risk of depressive symptoms than those without. The present study aimed to: assess the prevalence of
depression in a sample of children with SCD; evaluate the association between disease severity, social support and
depression, and the combined and/or singular effect on health-related quality of life (HRQL) in children with SCD;
and show the predictive value of social support and disease severity on depression.
Methods: A total of 120 children were included in the study, 60 (group I) with SCD and 60 matched, healthy
control children (group II). Depression was assessed in both groups using the Children’s Depression Inventory (CDI)
and the Children’s Depression Inventory-Parent (CDI-P). Children with CDI and CDI-P scores of more than 12 were
interviewed for further assessment of depression using the Diagnostic Interview Schedule for Children Version IV
(DISC-IV). The Pediatric Quality of Life Inventory Version 4.0 Generic Core Scales (PedsQL 4.0) was used to assess
HRQL in both groups, and social support was measured with the Child and Adolescent Social Support Scale
(CASSS).
Results: Eight (13%) of the 60 children with SCD had CDI and CDI-P scores of more than 12 (CDI mean score
14.50 ± 1.19, CDI-P mean score 14.13 ± 1.12), and were diagnosed as having clinical depression using the diagnostic
interview DISC-IV. For group I, HRQL was poor across all PedsQL 4.0 domains in both self- and parent-reports
(P < 0.001) compared with group II. A higher level of parent support was a significantly associated with decreased
depressive symptoms, demonstrated by lower CDI scores. Better quality of life was shown by the associated higher
total PedsQL 4.0 self-scores of children with SCD (B = −1.79, P = 0.01 and B = 1.89, P = 0.02 respectively).
Conclusions: The present study demonstrates that higher levels of parent support were significantly associated
with decreased depressive symptoms and better quality of life in children with SCD. Interventions focused on
increasing parent support may be an important part of treatment for depression in children with SCD.
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Sickle cell disease (SCD) is a group of chronic, recessively
inherited blood diseases, of which the most common type
is the homozygous SS state. The interaction of sickle
hemoglobin with other globin chain abnormalities also
results in clinically significant but often milder diseases,
for example, SC disease [1]. SCD can result in a host of
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severe pain episodes, delayed puberty, and academic
underachievement [2,3]. Depression is one of the most
common complications of chronic illnesses [4,5], and
childhood depression is a medical problem that can have
serious consequences if it is unrecognized and untreated
[6,7]. The majority of available studies have shown that
children with SCD have a higher risk of depressive symp-
toms [8-11], although some studies failed to show signifi-
cant levels of anxiety and depression [12]. In a recent
study, approximately half of the children and adolescents
with SCD were diagnosed with either dysthymia (90%) or
major depression (10%) [8]. Health-related quality of lifentral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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been studied, with the majority of these studies reporting
lower HRQL compared to normal controls [13-15]. Re-
searchers have reported that children and adolescents with
high perceived levels of social support have often been
found to have fewer adjustment problems [16-18]. A study
of sickle cell self-help support groups found that group
participation reduced feelings of depression and that the
longer patients participated in the group, the fewer psy-
chological symptoms they reported [19]. To the know-
ledge of the present authors, this is the first study that
assesses the association between various types of social
support and depression and quality of life in children with
sickle cell disease. The present study hypothesized that in-
creased social support is associated with decreased depres-
sive symptoms and better quality of life, and aimed to:
1. Assess the prevalence of depression in a sample of
children with SCD.
2. Evaluate the association between disease severity,
social support, and depression, and the combined
and/or singular effect on HRQL in children with SCD.
3. Show the predictive value of social support and
disease severity on depression.
Methods
Study design
The present study used a case–control design that in-
cluded 120 children; 60 with SCD, randomly selected (by
systematic random sampling) from the outpatient clinic
and inpatient Department of Pediatrics at King Abdulaziz
University Hospital in Jeddah, Saudi Arabia (group I), and
60 children as a matched, healthy control group (group II).
The study was conducted from January 2012 to January
2013. Both groups underwent psychological assessment for
comparison. The participating children were interviewed
with a parent present. Informed consent was obtained
from participants and their parents, and ethical approval
was obtained from the local ethical committee of King
Abdulaziz University Hospital.
Participants
The study sample consisted of two groups. Group I com-
prised 60 children with SCD aged 10–15. Exclusion criteria
were: a history of a previous cerebrovascular accident,
established by history-taking and reviewing the patient’s
medical records; any concomitant serious medical prob-
lems (other than those secondary to SCD except cerebro-
vascular accident), established by physical examination and
reviewing the patient’s medical records; any past or family
history of psychiatric disorder; and, any childhood disorder
such as mental retardation, autism, attention deficit
hyperkinetic disorder, and language barrier that may
interfere with the patient understanding and answeringthe interview questions. Group II comprised 60 matched,
healthy control children, aged 9–15, without any past or
family history of any psychiatric disorder and not receiving
any psychotropic medications (established by psychiatric
history-taking from the children and their parents). The
present study aimed to evaluate the association between
disease severity, social support, and depression as well as
the combined and/or singular effect on HRQL in children
with SCD. Participants’ sociodemographic data were re-
corded using a questionnaire developed by the study team.
Measures
Evaluation of depression
Depression was measured with: (1) The Children’s De-
pression Inventory (CDI) [20] which is a child self-report
inventory of depressive symptoms. It has high internal
consistency, test-retest reliability, and established validity
[21], with an alpha coefficient of 0.86. The CDI is the most
established and widely used measure of depressive symp-
toms for children [22,23]. The CDI is a 27-item scale ap-
propriate for children and adolescents aged 7–17 years,
and yields scores for five subscales: negative mood, inter-
personal problems, ineffectiveness, anhedonia, and nega-
tive self-esteem. There are three response options for each
item: 0 = absence of symptoms, 1 =moderate symptoms,
and 3 = severe symptoms, with higher scores indicating
increasing severity. The maximum score is 54, with a
score over 12 suggesting a depressive state. The CDI
can be used as a screening tool for depressive symptoms
in medically ill children [24,25]. In addition, the CDI
has been shown to be suitable for use with a mixed sam-
ple of in- and out-patients with chronic diseases and
acute conditions [25].
(2) The Children’s Depression Inventory-Parent (CDI-P)
[26] was used to assess the convergence of parent-report
with child-report of depression. The CDI-P is derived dir-
ectly from the CDI and is scored identically. It has high
test-retest reliability (0.75) and internal consistency (0.74),
is well correlated with the CDI [27] and has an alpha coef-
ficient of 0.88.
(3) Children with CDI and CDI-P scores of more than
12 were interviewed for further assessment of depression
using the Diagnostic Interview Schedule for Children,
Version IV (DISC-IV) [28]; a structured psychiatric diag-
nostic interview for children and adolescents aged 6–18
years, based on DSM IV diagnostic criteria. Although the
Diagnostic Interview Schedule for Children (DISC) was
designed to be used in large-scale epidemiological studies,
it has also been used as an adjunct in public health screen-
ing to increase the specificity of brief initial screening [29],
and has been used successfully in treatment studies to
assess inclusion and exclusion criteria [30]. The DISC
offers greater potential for standardization and reduced
error [28].
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Health-related quality of life (HRQL) was measured with
the Pediatric Quality of Life Inventory, Version 4.0 Gen-
eric Core Scales (PedsQL 4.0). This is a 23-item scale for
children and adolescents aged 8–18 years encompassing:
a) physical functioning (8 items); b) emotional functioning
(5 items); c) social functioning (5 items); and, d) school
functioning (5 items) [31,32]. The physical health sum-
mary score (8 items) is the same as the physical func-
tioning scale. The psychosocial health summary score
(15 items) combines the emotional, social and school
functioning scales; the mean is computed as the sum of
the items divided by the number of items answered in
these scales. The instrument takes approximately 5 minutes
to complete [32]. The Peds QL 4.0 comprises parallel child
self-report and parent proxy-report formats. This scale
construct consistency facilitates the evaluation of differ-
ences in HRQL across and between age groups, as well as
the tracking of HRQL longitudinally. The instrument asks
how much of a problem each item has been during the
past 1-month period. Five-point Likert response scales are
used for both the child self-report and the parent proxy-
report (0 = never a problem; 1 = almost never a problem;
2 = sometimes a problem; 3 = often a problem; 4 = almost
always a problem). Items are reversed; scored, and linearly
transformed to a scale of 0–100 (0 = 100, 1 = 75, 2 = 50,
3 = 25, 4 = 0); higher scores indicate better HRQL. Scale
scores are computed as the sum of the items divided by
the number of items answered. The PedsQL 4.0 is a
brief, generic measure that is widely used to assess
HRQL in a range of illness groups. In clinical practice,
routine clinical screening with PedsQL 4.0 has signifi-
cant clinical utility [33].
Evaluation of social support
Social support was measured with the Child and Adoles-
cent Social Support Scale (CASSS) [34], which assesses a
child’s perception of social support from four sources:
teacher(s), classmates, parent(s), and close friends. Each
score has 12 items. Scores were calculated by averaging
the children’s frequency ratings from 1 (never) to 6 (al-
ways) for each item within the four types of support.
Higher scores indicate higher perception of support. The
CASSS has been well studied and has strong psychomet-
ric properties, with an alpha coefficient of 0.92 [35]. The
CASSS is an appropriate measure of perceived social
support for use with children and adolescents [34]. Other
commonly used measures of social support for children
such as the Social Skills Rating System (SSRS) [36]and the
Student Self-Concept Scale (SSCS) [37]are used to meas-
ure how students feel or what they do, while the CASSS
measures how children and adolescents feel about what
others do to them or how others support them. The
CASSS is a measure of perceived social support that ismultidimensional and can advance understanding of the
role of social support in the lives of children [34].
Evaluation of disease severity
Disease severity in the present study was assessed using
a binary classification of mild and severe according to spe-
cific parameters: 1) type of sickle cell disease. Sickle cell
anemia (HB SS) is considered to be the most severe of the
clinical syndromes, followed by sickle [B]-thalassemia (HB
SB+) and HB SC disease [38]. The phenotype of SCD has
been used as an index of disease severity in other studies
[39,40]; 2) chronic transfusion therapy; 3) evidence of end
organ damage with complications; 4) 12 or more medical
visits for pain in the preceding 12 months; and, 5) three or
more hospitalizations required per year. Participants who
met none of these parameters were classified as having a
mild disease. Similar indices of disease severity have been
used in previous studies [41,42].
Statistical analysis
The data analyses were performed using the statistical
package for social sciences software (IBM SPSS Statis-
tics, Version 20). Categorical data were presented in the
form of number and percentage, while quantitative data
were presented in the form of mean and standard devi-
ation. Groups were compared using independent sample
t-tests for quantitative parameters (95% CI). For qualitative
variables, chi-square was used as a test of significance of
differences among groups. Multiple linear regression was
used in the analysis of the data. A P value of < 0.05 was
considered to indicate statistical significance. The regres-
sion analysis included depression as both an independent
variable (to show the predictive value of depression on
HRQL) and a dependent variable (to determine the pre-
dictive value of social support and disease severity on
depression).
Results
– A total of 120 children participated in the present
study. Of the 60 children with SCD (group I), 42
(70%) had HB SS, 16 (26.7%) had HB SB+, and 2
(3.3%) had HB SC disease. Forty-one children
(68.3%) had severe SCD and 19 (31.7%) a mild form
of the disease.
– Eight (13%) of the 60 children with SCD scored
more than 12 on the CDI (mean score 14.50 ± 1.19)
and on the CDI-P (mean score 14.13 ± 1.12). The
clinical interviews with these eight children, using
the DISC-IV, identified these children as having
clinical depression (0% false-positive rate).
– As shown in Table 1, group I had significantly
poorer academic performance compared with group
II. No other significant differences were found
Table 1 Demographic characteristics of children with SCD (Group I) versus healthy children (Group II)
Variable Group I (N = 60) Group II (N = 60) Significance CI (95%)
M SD M SD t p
Age 11.93 1.72 11.77 1.96 0.35 0.7 −0.78 – 1.12
Range (10–15) (9–15)
N % N % χ2 p
Gender 0.31 0.5
Male 24 40 27 45
Female 36 60 33 55
Nationality 1.22 0.2
Saudi 29 48.3 23 38.3
Non-Saudi 31 51.7 37 61.7
Education 0.27 0.6
Elementary schoo 34 56.6 39 65
Intermediate school 26 43.4 21 35
Academic performance 4.36 0.03*
Good 44 73.3 53 88.3
Poor 16 26.7 7 11.7
Family income per month 3.3 0.1
<SR.3000 9 15 7 11.6
SR.3000-5000 29 48.3 21 35
>SR.5000 22 36.7 32 53.4
*P < 0.05 significant. SCD: Sickle cell disease.
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nationality, education, and family income.
– Table 2 shows that group I had significantly higher
CDI and CDI-P mean scores, and significantly lower
PedsQL 4.0 mean scores (self and parent report) in
all domains, than children in group II.
– The multiple linear regression model used to assess
the predictors of depression in children with SCD
showed that a higher level of parent support was
the only significant predictor associated with lower
depressive states (reflected by associated lower
CDI scores) in children with SCD (B = −1.79 and
P = 0.01) (Table 3).
– The multiple linear regression model used to assess
the predictors of quality of life in children with SCD
showed that a higher level of parent support was a
significant predictor associated with better quality
of life, reflected by associated higher total PedsQL
4.0 self-scores in children with SCD (B = 1.89 and
P = 0.02). Higher CDI scores and increased disease
severity were significant predictors associated with
poor quality of life, reflected by associated lower
total PedsQL 4.0 self-scores in children with SCD
(B = −1.70, P = 0.04 and B = −2.46, P = 0.002
respectively) (Table 4).Discussion
To the knowledge of the present authors, this is the first
study that assesses the association between various types
of social support, depression, and quality of life in children
with SCD. Our study demonstrated that the prevalence of
depression in children with SCD was 13%, a finding con-
sistent with previous studies [9-11,43]. In a recent study,
Jerrell et al [8] reported that the prevalence major depres-
sion in children and adolescents with SCD was 10%. How-
ever, in contrast to our findings, Noll et al [44] evaluated
depression in a group of children aged 8–15 with SCD
using the CDI, and reported that no differences were
found between children with SCD and healthy children
(the control group). This highlights that studies in this
field continue to have conflicting results and further re-
search is required. In addition, data for Noll et al’s study
was collected at home when children were not acutely ill
rather than in a hospital setting, and interviews at home
may differ from those conducted in outpatient settings. In
the present study, quality of life in all domains was sig-
nificantly impaired (reflected in the lower PedsQL 4.0
mean self- and parent-scores in all domains) in children
with SCD compared with healthy children (Table 2); a
finding that is consistent with previous studies [13-15,45].
Panepinto et al [46] used the PedsQL 4.0 to determine the
Table 2 CDI, CDI-P, and PedsQL 4.0 mean scores comparison between children with SCD (Group I) and healthy children
(Group II)
Variable Group I (N = 60) Group II (N = 60) Significance CI (95%)
M SD M SD t p
CDI 9.50 2.57 7.50 1.81 3.48 0.001 0.85 – 3.15
CDI-P 8.93 3.54 7.20 1.58 2.44 0.01 0.31 – 3.16
Total score <0.001
Self 75.40 2.83 81.33 3.46 −7.25 −7.57 – -4.29
Parent 75.20 2.56 82.73 4.41 −8.07 <0.001 −9.40 – -5.66
Physical health <0.001
Self 77.73 2.43 82.01 2.49 −6.70 -.54 – -2.99
Parent 71.87 1.67 80.80 4.24 −10.71 <0.001 −10.60 – -7.26
Psycho-social health Self 76.37 4.51 81.63 2.52 −5.57 <0.001 −7.15 – -3.37
Parent 76.01 4.16 82.43 4.40 −5.80 <0.001 −8.65 – -4.21
Emotional functioning 0.03
Self 76.60 9.65 80.57 2.58 −2.17 −7.62 – -0.31
Parent 76.83 3.79 80.56 4.09 −3.66 0.001 −5.77 – -1.69
Social functioning <0.001
Self 76.17 2.62 83.40 3.66 −8.78 −8.88 – -5.58
Parent 76.53 2.38 83.47 5.05 −6.79 <0.001 −8.97 – -4.89
School functioning <0.001
Self 74.33 2.27 81.01 3.04 −9.61 - 8.05 – -5.27
Parent 72.97 2.64 82.30 3.72 −11.19 <0.001 −11.00 – -7.66
P < 0.05 significant. SCD: Sickle cell disease, CDI: Children’s Depression Inventory, CDI-P: Children’s Depression Inventory-Parent, PedsQL: Pediatric Quality of Life.
Sehlo and Kamfar BMC Psychiatry  (2015) 15:78 Page 5 of 8impact of family income and SCD on HRQL of children
with SCD compared with children without the disease,
and concluded that children with SCD have significantly
impaired HRQL, even after considering the potential det-
rimental effect of family income on HRQL. In a more re-
cent study, Dale et al [47] reported that both children with
SCD and their parents rated overall HRQL and all subdo-
mains of HRQL lower than did healthy children and their
parents, a finding that matched our results. Many studies
have reported that management of SCD complicationsTable 3 Predictors of depression in children with SCD analyze
dependent variable




CDI scores F = 3.62 Teacher supp




*P < 0.05 significant. SCD: Sickle cell disease, CDI: Children’s Depression Inventory.may require hospitalization, therefore affecting attendance
at school and normal play activities. These hospitalizations
and school absences could be expected to have a negative
impact on the health-related quality of life for children
and adolescents with SCD [13,14,48,49].
The primary aim of the present study was to evaluate
the association between disease severity, social support,
and depression, and the combined and/or singular effect
on HRQL in children with SCD. Our study found that
disease severity and depression were associated withd by multiple linear regression, with CDI scores as the
t variables B t p
0.33 1.46 0.1
0.073 0.92 0.3
ity 0.047 0.67 0.7
ort −0.004 −0.046 0.9
pport −0.007 −0.081 0.9
rt −1.79 −2.73 0.01*
upport −0.29 −1.14 0.2
italization 0.049 0.65 0.7
Table 4 QOL predictors in children with SCD analyzed by multiple linear regression; total PedsQL 4.0 self-scores as the
dependent variable
Dependent variable Model Independent variables B t p
Age 0.079 1.04 0.3
PedsQL total self Adjusted R2= Gender 0.072 0.85 0.7
scores 0.28 Disease severity −2.46 −3.54 0.002*
F = 11.95 CDI −1.70 −2.13 0.04*
P = 0.002 Teacher support 0.12 1.36 0.2
Classmates support 0.10 1.13 0.2
Parent support 1.89 2.79 0.02*
Close friend support 0.11 1.31 0.2
Effect of hospitalization 0.13 1.34 0.2
*P < 0.05 significant. SCD: Sickle cell disease, QOL: Quality of Life, PedsQL: Pediatric Quality of Life.
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[45] reported that disease status was associated with
impaired physical HRQL. Gil et al [50] reported that
negative mood was associated with increases in same-
day pain, health-care use, and reductions in school and
social activity, while increases in positive mood were as-
sociated with decreases in pain, less health-care use, and
more activity participation in adolescents with SCD (aged
13 to 17 years). Many researchers have examined the risk
factors for developing emotional and behavioral difficulties
in children; however, there has been increasing interest in
the factors that promote resiliency in vulnerable children
[51]. Social support is closely related to resiliency in vul-
nerable children, the presence of supportive parents or
teachers have been identified as buffers for vulnerable
children [51,52]. In our study, we examined the various
types of social support that could play a role in resiliency
in children with SCD (parent, teacher, classmate, and close
friend support) to identify the most effective subtype of
social support that is associated with resiliency in children
with SCD. In addition, assessment of social support from
multiple sources can advance understanding of the role of
social support in the lives of children, and may enhance
the development of appropriate interventions for children
in need [34]. In the present study, of the various types of
social support, only an increased level of parent support
was significantly associated with decreased depressive
symptoms and better quality of life in children with SCD
(Tables 3 and 4). This means our hypothesis that increased
social support is associated with decreased depressive
symptoms and better quality of life is only accepted for
parent support and rejected for the other types of social
support (teacher, classmate, and close friend support). A
support intervention study including a combination of so-
cial support plus counseling to patients with SCD found
that after the intervention, patients had fewer emergency
department visits and hospitalizations compared with pre-
treatment [53]. This indicates that support intervention isan important part of treatment of children with SCD, es-
pecially focusing on increasing the parent support that
leads to decreased depressive symptoms, buffering the ser-
ious consequences of depression, and improving quality of
life, which, in turn, decreases emergency department visits
and hospitalizations.
Conclusions
The present study demonstrated that a higher level of par-
ent support was significantly associated with decreased de-
pressive symptoms and better quality of life in children
with SCD. Specific support interventions focusing on in-
creasing parent support may be an important part of treat-
ment of depression in children with SCD.
Limitations
This was a cross-sectional study. Longitudinal, prospective
studies may provide more reliable data on the relationship
between increased parental support and decreased depres-
sive symptoms and better quality of life. In addition, the
present study did not delineate what quality/type of sup-
port might be most important (i.e., tangible, emotional,
etc.), which suggests further research is necessary to pro-
vide guidance for an integrated approach to the care of
these chronically ill children and adolescents.
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